ATOSSA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount
ATOSSA THERAPEUTICS, INC. (ATOS) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount of $246.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-25
- ATOSSA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2024 was $246.00K, a 63.93% decline from fiscal 2023.
- ATOSSA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2023 was $682.00K, a 220.19% increase from fiscal 2022.
- ATOSSA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2022 was $213.00K.
- ATOSSA THERAPEUTICS, INC. effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, amount for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | $246.00K 10-K · filed 2026-03-25 | |
| 2023-12-31 | $682.00K 10-K · filed 2025-03-25 | |
| 2022-12-31 | $213.00K 10-K · filed 2024-04-01 | |
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 | |
| 2020-12-31 | $26.00K 10-K · filed 2022-02-28 | $26.11K 10-K · filed 2021-03-31 |
| 2019-12-31 | $661.89K 10-K · filed 2021-03-31 | |
| 2018-12-31 | $169.96K 10-K · filed 2020-03-26 | |
| 2017-12-31 | $197.34K 10-K · filed 2019-03-28 | |
| 2016-12-31 | $214.43K 10-K · filed 2018-03-08 | |
| 2015-12-31 | $194.68K 10-K/A · filed 2017-03-21 | |
| 2014-12-31 | $36.10K 10-K · filed 2016-03-30 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |